My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Genetic risk assessment and BRCA mutation testing.

    Ormond KE, Bellcross C, Weissman S.

    Ann Intern Med. 2006 Feb 21;144(4):303-4; discussion 304. No abstract available. PMID: 16490919 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.

    Wolff TA, Wilson JE.

    Am Fam Physician. 2006 Nov 15;74(10):1759-60. Review. No abstract available. PMID: 17137007 [PubMed - indexed for MEDLINE]Related articles

    3.

    Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.

    [No authors listed]

    Ann Intern Med. 2005 Sep 6;143(5):I47. No abstract available. PMID: 16144889 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hereditary breast-ovarian cancer: clinical findings and medical management.

    Marshall M, Solomon S.

    Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.PMID: 17901820 [PubMed - indexed for MEDLINE]Related articles

    5.

    The need for public education: "Surveillance and risk reduction strategies" for women at risk for carrying BRCA gene mutations.

    Nisker JA.

    J Obstet Gynaecol Can. 2007 Jun;29(6):510-1. No abstract available. PMID: 17568484 [PubMed - indexed for MEDLINE]Related articles

    6.

    Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2005 Sep 6;143(5):355-61. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547. PMID: 16144894 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Choices--and uncertainties--for women with BRCA mutations.

    Couzin J.

    Science. 2003 Oct 24;302(5645):592. No abstract available. PMID: 14576419 [PubMed - indexed for MEDLINE]Related articles

    8.

    Genetic risk assessment and BRCA mutation testing.

    Eisinger F, Horsman DE.

    Ann Intern Med. 2006 Mar 7;144(5):376; author reply 376-7. No abstract available. PMID: 16520482 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Inherited breast and ovarian cancers]

    Gerdes AM, Ejlertsen B.

    Ugeskr Laeger. 2006 Jun 12;168(24):2367-9. Danish. PMID: 16822422 [PubMed - indexed for MEDLINE]Related articles

    10.

    Risk modeling in breast cancer.

    Euhus D.

    Breast J. 2004 Jan-Feb;10 Suppl 1:S10-2.PMID: 14984482 [PubMed - indexed for MEDLINE]Related articles

    11.

    Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.

    Brooks GA, Stopfer JE, Erlichman J, Davidson R, Nathanson KL, Domchek SM.

    Cancer Biol Ther. 2006 Sep;5(9):1098-102. Epub 2006 Sep 11.PMID: 16931905 [PubMed - indexed for MEDLINE]Related articles

    12.

    Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.

    Spannuth WA, Thaker PH, Sood AK.

    Am J Obstet Gynecol. 2007 Apr;196(4):e6-9.PMID: 17403394 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics.

    Eccles DM.

    Ann Oncol. 2004;15 Suppl 4:iv133-8. Review. No abstract available. PMID: 15477297 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Optimal selection of individuals for BRCA mutation testing.

    Evans DG, Lalloo F, Eccles D.

    J Clin Oncol. 2006 Jul 10;24(20):3311; author reply 3311-2. No abstract available. PMID: 16829657 [PubMed - indexed for MEDLINE]Related articles

    15.

    Breast and ovarian cancer: a new model for educating women.

    Mangerich B, Stichler JF.

    Nurs Womens Health. 2008 Dec;12(6):490-9. Review. No abstract available. PMID: 19121054 [PubMed - indexed for MEDLINE]Related articles

    16.

    Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer.

    Calzone KA, Prindiville SA, Jourkiv O, Jenkins J, DeCarvalho M, Wallerstedt DB, Liewehr DJ, Steinberg SM, Soballe PW, Lipkowitz S, Klein P, Kirsch IR.

    J Clin Oncol. 2005 May 20;23(15):3455-64.PMID: 15908654 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hereditary Breast and ovarian cancer: providing personalized medicine.

    Tranin AS.

    AWHONN Lifelines. 2005 Oct-Nov;9(5):372-6. Review. No abstract available. PMID: 16359075 [PubMed - indexed for MEDLINE]Related articles

    18.

    Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.

    James PA, Harris M, Lindeman GJ, Mitchell G.

    J Med Genet. 2008 Nov;45(11):765-6. No abstract available. PMID: 18978334 [PubMed - indexed for MEDLINE]Related articles

    19.

    Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

    Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER.

    BMC Cancer. 2008 May 30;8:155.PMID: 18513387 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Cancer. A risky business--assessing breast cancer risk.

    Levy-Lahad E, Plon SE.

    Science. 2003 Oct 24;302(5645):574-5. No abstract available. PMID: 14576407 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity